Australia markets closed

Immunic, Inc. (IMUX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
0.9807-0.0993 (-9.19%)
At close: 04:00PM EDT
1.0202 +0.04 (+4.03%)
After hours: 07:53PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close1.0800
Open1.0700
Bid0.9661 x 100
Ask1.0300 x 100
Day's range0.9700 - 1.1100
52-week range0.9450 - 3.1100
Volume932,632
Avg. volume238,445
Market cap88.34M
Beta (5Y monthly)1.83
PE ratio (TTM)N/A
EPS (TTM)-1.8300
Earnings date01 Aug 2024 - 05 Aug 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target est11.50
  • Simply Wall St.

    When Will Immunic, Inc. (NASDAQ:IMUX) Breakeven?

    With the business potentially at an important milestone, we thought we'd take a closer look at Immunic, Inc.'s...

  • PR Newswire

    Immunic to Participate in Industry and Scientific Conferences in June

    Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced participation in the following industry and scientific conferences in June:

  • Insider Monkey

    Immunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript

    Immunic, Inc. (NASDAQ:IMUX) Q1 2024 Earnings Call Transcript May 8, 2024 Immunic, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Jessica Breu: Good morning, and welcome to Immunic First Quarter 2024 Earnings Call. My name is Jessica Breu, Vice President, […]